Case Report

Split Viewer

Korean J Hematol 2012; 47(2):

Published online June 26, 2012

https://doi.org/10.5045/kjh.2012.47.2.150

© The Korean Society of Hematology

Successful treatment of disseminated interdigitating dendritic cell sarcoma with adriamycin, bleomycin, vinblastine, and dacarbazine chemotherapy

Suk-young Lee1, Se Ryeon Lee1, Won Jin Chang1, Hye Sook Kim1, Byung Soo Kim1, and In Sun Kim2*

1Department of Hemato-oncology, Korea University Medical Center, Anam Hospital, Seoul, Korea.

2Department of Pathology, Korea University Medical Center, Anam Hospital, Seoul, Korea.

Correspondence to : Correspondence to In Sun Kim, M.D., Ph.D. Department of Pathology, Korea University Medical Center, Anam Hospital, Anam-dong 5 ga, Sungbuk-gu, Seoul 152-703, Korea. Tel: +82-2-920-5594, Fax: +82-2-953-3130, iskim@korea.ac.kr

Received: September 7, 2011; Revised: October 22, 2011; Accepted: February 20, 2012

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Interdigitating dendritic cell sarcoma (IDCS) is a very rare and aggressive neoplasm that arises from antigen presenting cells. IDCS usually involves lymph nodes; however, extra-nodal involvement has also been reported. Because a consistent standard therapy for IDCS has not been established to date, we report a case of the successful treatment of disseminated IDCS using ABVD chemotherapy (doxorubicin, bleomycin, vinblastine, and dacarbazine). A 64-year-old man was diagnosed with IDCS on the basis of immunohistochemical findings of a biopsy specimen of the inferior nasal concha. Immunohistochemical staining showed a positive reaction for CD68, leukocyte common antigen, and S-100 protein, but a negative reaction for CD34, CD1a, and CD21. Imaging studies showed cervical and axillary lymphadenopathies, subcutaneous nodules, and a soft tissue lesion in the nasal cavity. Treatment with the ABVD regimen resulted in complete remission after 8 cycles of chemotherapy.

Keywords IDCS, ABVD chemotherapy, Complete remission

Article

Case Report

Korean J Hematol 2012; 47(2): 150-153

Published online June 26, 2012 https://doi.org/10.5045/kjh.2012.47.2.150

Copyright © The Korean Society of Hematology.

Successful treatment of disseminated interdigitating dendritic cell sarcoma with adriamycin, bleomycin, vinblastine, and dacarbazine chemotherapy

Suk-young Lee1, Se Ryeon Lee1, Won Jin Chang1, Hye Sook Kim1, Byung Soo Kim1, and In Sun Kim2*

1Department of Hemato-oncology, Korea University Medical Center, Anam Hospital, Seoul, Korea.

2Department of Pathology, Korea University Medical Center, Anam Hospital, Seoul, Korea.

Correspondence to: Correspondence to In Sun Kim, M.D., Ph.D. Department of Pathology, Korea University Medical Center, Anam Hospital, Anam-dong 5 ga, Sungbuk-gu, Seoul 152-703, Korea. Tel: +82-2-920-5594, Fax: +82-2-953-3130, iskim@korea.ac.kr

Received: September 7, 2011; Revised: October 22, 2011; Accepted: February 20, 2012

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Interdigitating dendritic cell sarcoma (IDCS) is a very rare and aggressive neoplasm that arises from antigen presenting cells. IDCS usually involves lymph nodes; however, extra-nodal involvement has also been reported. Because a consistent standard therapy for IDCS has not been established to date, we report a case of the successful treatment of disseminated IDCS using ABVD chemotherapy (doxorubicin, bleomycin, vinblastine, and dacarbazine). A 64-year-old man was diagnosed with IDCS on the basis of immunohistochemical findings of a biopsy specimen of the inferior nasal concha. Immunohistochemical staining showed a positive reaction for CD68, leukocyte common antigen, and S-100 protein, but a negative reaction for CD34, CD1a, and CD21. Imaging studies showed cervical and axillary lymphadenopathies, subcutaneous nodules, and a soft tissue lesion in the nasal cavity. Treatment with the ABVD regimen resulted in complete remission after 8 cycles of chemotherapy.

Keywords: IDCS, ABVD chemotherapy, Complete remission

Fig 1.

Figure 1.

Histological features of the nasal cavity include diffuse infiltration of spindle cells, large pleomorphic cells, foamy histiocytes, and various inflammatory cells (A). Immunohistochemical staining shows a strong positive reaction for S-100 protein (B).

Blood Research 2012; 47: 150-153https://doi.org/10.5045/kjh.2012.47.2.150

Fig 2.

Figure 2.

Computed tomography (CT) scans show multiple lymphadenopathies in both axillae (A) and lymphadenopathies on both sides of the neck (B).

Blood Research 2012; 47: 150-153https://doi.org/10.5045/kjh.2012.47.2.150

Fig 3.

Figure 3.

CT scans after 8 cycles of ABVD (adriamycin, bleomycin, vinblastine, and dacarbazine) shows complete resolution of axillary lymphadenopathies (A) and cervical lymphadenopathies (B).

Blood Research 2012; 47: 150-153https://doi.org/10.5045/kjh.2012.47.2.150
Blood Res
Volume 59 2024

Stats or Metrics

Share this article on

  • line

Related articles in BR

Blood Research

pISSN 2287-979X
eISSN 2288-0011
qr-code Download